Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 976 to 1000 of about 5928

Previous 25

Website Changes

03/20/2020

German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany

03/19/2020

5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery

03/16/2020

Researchers Uncover Racial Disparities in Brain Cancer Outcomes

03/16/2020

Rindopepimut With Bevacizumab for Patients With Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

03/14/2020

Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis

03/14/2020

First-line Bevacizumab Contributes to Survival Improvement in Glioblastoma Patients Complementary to Temozolomide

03/14/2020

Tamoxifen Is a Candidate First-In-Class Inhibitor of Acid Ceramidase That Reduces Amitotic Division in Polyploid Giant Cancer cells-Unrecognized Players in Tumorigenesis

03/14/2020

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

03/14/2020

Ketogenic Diets as an Adjuvant Therapy for Glioblastoma (KEATING): A Randomized, Mixed Methods, Feasibility Study

03/13/2020

Optune Open Houses are now availble as webinars!

03/12/2020

Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy

03/10/2020

An innovative drug trial for brain cancer begins at UAB

02/20/2020

The American Brain Tumor Association’s 2020 Regional Patient and Family Meeting is coming to New York!

02/19/2020

DelMar Pharmaceuticals [Nasdaq:DMPI] Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 For First-Line Treatment of Brain Tumors

02/18/2020

Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

02/14/2020

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy.

02/13/2020

DIPG / DMG Registry Family Update Webinar

02/12/2020

Data Favor Max Resection for All Glioblastomas

02/12/2020

Crowdfunding cancer treatment to fill an unmet need

02/12/2020

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.

02/12/2020

Accelerating Children’s Access to New Treatments for High Risk Brain Tumors

02/09/2020

‘Fail first’ no more: Pennsylvania moves to expand coverage of treatments for advanced cancers

02/05/2020

Outside-The-Box Treatment Helps Teen With Aggressive Brain Cancer

02/05/2020

Musella Foundation Copayment Assistance Program Closed to New patient

02/04/2020

A Moonshot for Kids: Congressional Briefing Scheduled for Childhood Brain Cancer Advocacy Group`s Plea for Awareness

Our privacy / cookie policy has changed.
Click HERE to read it!